Page last updated: 2024-09-02

2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one and guanidinosuccinic acid

2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one has been researched along with guanidinosuccinic acid in 1 studies

Compound Research Comparison

Studies
(2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one)
Trials
(2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one)
Recent Studies (post-2010)
(2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one)
Studies
(guanidinosuccinic acid)
Trials
(guanidinosuccinic acid)
Recent Studies (post-2010) (guanidinosuccinic acid)
56029636

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Deyn, PP; Macdonald, RL1

Other Studies

1 other study(ies) available for 2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one and guanidinosuccinic acid

ArticleYear
Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture.
    Annals of neurology, 1990, Volume: 28, Issue:5

    Topics: Animals; Brain Chemistry; Cells, Cultured; Creatinine; Drug Synergism; GABA Antagonists; Glycine; Guanidine; Guanidines; Methylguanidine; Mice; Neurons; Pyrazoles; Spinal Cord; Succinates; Uremia

1990